SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-099200
Filing Date
2021-03-30
Accepted
2021-03-30 08:17:59
Documents
4
Period of Report
2021-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d115194d8k.htm 8-K 23193
2 EX-1.1 d115194dex11.htm EX-1.1 150961
3 EX-5.1 d115194dex51.htm EX-5.1 8873
4 GRAPHIC g115194dsp1.jpg GRAPHIC 3933
  Complete submission text file 0001193125-21-099200.txt   189815
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 21783728
SIC: 2836 Biological Products, (No Diagnostic Substances)